Biomarker-Guided Drug Repurposing and Molecular Validation of Angiotensin-2 Receptor Type-1 in Brain Tumor. Precis. Med. Com. 2023, 3 (1), 27-42. https://doi.org/10.55627/pmc.003.01.0296.